There is arguments at Novartis, the boss CEO has been criticised by investors and board for not investing enough for the future. Could be the reason why they didn’t invest in MSB. That’s they link from the Swiss paper Blick. Sorry my English is not the best.
https://www.blick.ch/wirtschaft/muss-vas-narasimhanhttps://www.blick.ch/wirtschaft/muss-vas-narasimhan-bald-gehen-insider-beklagen-personenkult-beim-novartis-chef-id17098925.html?utm_medium=social&utm_campaign=share-button&utm_source=copy-to-clipboard-bald-gehen-insider-beklagen-personenkult-beim-novartis-chef-id17098925.html?utm_medium=social&utm_campaign=share-button&utm_source=copy-to-clipboardhttps://www.blick.ch/wirtschaft/muss-vas-narasimhan-bald-gehen-insider-beklagen-personenkult-beim-novartis-chef-id17098925.html?utm_medium=social&utm_campaign=share-button&utm_source=copy-to-clipboard
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD, page-90
-
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |